Literature DB >> 9873397

In vitro evaluation and crystallographic analysis of a new class of selective, non-amide-based thrombin inhibitors.

T Lu1, B Tomczuk, C R Illig, R Bone, L Murphy, J Spurlino, F R Salemme, R M Soll.   

Abstract

We describe the in vitro evaluation and crystallographic analysis of a new class of potent and selective, non-amino acid-based, small-molecule thrombin inhibitors, exemplified by 14. This class of achiral inhibitors lacks an amide-based backbone, exhibits nM inhibition of thrombin, and is selective for thrombin. Compound 14 does not interact with the active-site catalytic apparatus and is anchored to the enzyme via a single network of hydrogen bonds to Asp189 of the S1 pocket.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9873397     DOI: 10.1016/s0960-894x(98)00290-x

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  New synthetic thrombin inhibitors: molecular design and experimental verification.

Authors:  Elena I Sinauridze; Alexey N Romanov; Irina V Gribkova; Olga A Kondakova; Stepan S Surov; Aleksander S Gorbatenko; Andrey A Butylin; Mikhail Yu Monakov; Alexey A Bogolyubov; Yuryi V Kuznetsov; Vladimir B Sulimov; Fazoyl I Ataullakhanov
Journal:  PLoS One       Date:  2011-05-16       Impact factor: 3.240

2.  Study of the Differential Activity of Thrombin Inhibitors Using Docking, QSAR, Molecular Dynamics, and MM-GBSA.

Authors:  Karel Mena-Ulecia; William Tiznado; Julio Caballero
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.